Letter to the Editor
Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab: comment
Anakinra, una alternativa potencial en el tratamiento de la infección respiratoria grave por SARS-CoV-2 refractaria a tocilizumab: comentario
Read
13
Timeswas read the article
5
Total PDF
6
Total HTML
2
Total EPUB
| Year/Month | Html | Epub | Total | |
|---|---|---|---|---|
| 2023 March | 5 | 5 | 2 | 12 |
| 2023 February | 0 | 0 | 0 | 0 |
| 2023 January | 0 | 0 | 0 | 0 |
| 2022 December | 0 | 0 | 0 | 0 |
| 2022 November | 0 | 0 | 0 | 0 |
| 2022 October | 0 | 0 | 0 | 0 |
| 2022 September | 0 | 0 | 0 | 0 |
| 2022 August | 1 | 0 | 0 | 1 |
| 2022 July | 0 | 0 | 0 | 0 |
| 2022 June | 0 | 0 | 0 | 0 |
